tm
Seeing Is Believing
tm
Seeing Is Believing
BPMC is currently covered by 20 analysts with an average potential upside of $20.46 (32.11%) backed by displayed 129 price targets and 189 ratings.
Analysts average stock forecasts to be materialized ratio is 62.19% with an average time for these price targets to be met of 141.35 days.
Highest price target for BPMC is 110, Lowest price target is 38, average price target is 74.
Most recent stock forecast was given by AMI FADIA from NEEDHAM on 27-Oct-2023. First documented stock forecast 29-Nov-2016.
Currently, out of the existing stock ratings of BPMC - 49 which are a Buy (58.33%), 29 which are a Hold (34.52%), 6 which are a Sell (7.14%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
74
$4.3 (6.17%)
66
1 months 4 days ago
9/10 (90%)
$13.15 (27.03%)
103
Hold
63
$-6.7 (-9.61%)
59
1 months 4 days ago
8/10 (80%)
$13.3 (22.54%)
139
Hold
85
$15.3 (21.95%)
1 months 4 days ago
0/3 (0%)
$24.91 (42.80%)
Hold
58
$-11.7 (-16.79%)
46
1 months 4 days ago
7/7 (100%)
$0.9 (2.88%)
75
Buy
114
3 months 24 days ago
2/5 (40%)
$44.97 (61.98%)
273
What is BPMC (Blueprint Medicines) average time for price targets to be met?
Which analyst has the current highest performing score on BPMC (Blueprint Medicines) with a proven track record?
Which analyst has the most public recommendations on BPMC (Blueprint Medicines)?
Which analyst is the currently most bullish on BPMC (Blueprint Medicines)?
Which analyst is the currently most reserved on BPMC (Blueprint Medicines)?
